26,279 Shares in Bath & Body Works, Inc. $BBWI Acquired by Caprock Group LLC

Caprock Group LLC bought a new position in Bath & Body Works, Inc. (NYSE:BBWI) in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 26,279 shares of the company’s stock, valued at approximately $677,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of the business. Royal Bank of Canada increased its stake in shares of Bath & Body Works by 92.8% in the 1st quarter. Royal Bank of Canada now owns 59,877 shares of the company’s stock valued at $1,815,000 after acquiring an additional 28,815 shares in the last quarter. Goldman Sachs Group Inc. raised its holdings in shares of Bath & Body Works by 15.7% during the first quarter. Goldman Sachs Group Inc. now owns 645,970 shares of the company’s stock valued at $19,586,000 after purchasing an additional 87,529 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in shares of Bath & Body Works by 7.0% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 562,757 shares of the company’s stock worth $17,063,000 after purchasing an additional 36,684 shares in the last quarter. Intech Investment Management LLC acquired a new stake in shares of Bath & Body Works in the 1st quarter valued at about $1,155,000. Finally, Geneos Wealth Management Inc. grew its stake in shares of Bath & Body Works by 217.7% in the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock valued at $35,000 after buying an additional 801 shares during the period. 95.14% of the stock is currently owned by institutional investors.

Bath & Body Works Price Performance

BBWI opened at $24.07 on Tuesday. Bath & Body Works, Inc. has a 1 year low of $14.27 and a 1 year high of $41.87. The company has a market capitalization of $4.93 billion, a price-to-earnings ratio of 7.41, a P/E/G ratio of 1.06 and a beta of 1.54. The firm’s fifty day moving average price is $21.44 and its two-hundred day moving average price is $24.01.

Bath & Body Works (NYSE:BBWI) last released its quarterly earnings results on Thursday, November 20th. The company reported $0.35 earnings per share for the quarter, missing analysts’ consensus estimates of $0.40 by ($0.05). Bath & Body Works had a net margin of 9.50% and a negative return on equity of 47.35%. The firm had revenue of $1.59 billion for the quarter, compared to the consensus estimate of $1.64 billion. During the same period in the previous year, the business earned $0.49 earnings per share. The firm’s revenue for the quarter was down 1.0% on a year-over-year basis. Bath & Body Works has set its FY 2025 guidance at 2.870- EPS and its Q4 2025 guidance at 1.700- EPS. As a group, equities analysts anticipate that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, March 6th. Stockholders of record on Friday, February 20th will be issued a $0.20 dividend. The ex-dividend date of this dividend is Friday, February 20th. This represents a $0.80 annualized dividend and a dividend yield of 3.3%. Bath & Body Works’s dividend payout ratio is currently 24.62%.

Analyst Ratings Changes

Several brokerages have issued reports on BBWI. Robert W. Baird set a $20.00 price target on Bath & Body Works in a report on Wednesday, December 17th. The Goldman Sachs Group cut Bath & Body Works from a “buy” rating to a “neutral” rating and cut their target price for the stock from $39.00 to $17.00 in a report on Thursday, November 20th. Morgan Stanley reissued an “equal weight” rating and issued a $18.00 price target (down previously from $43.00) on shares of Bath & Body Works in a research report on Friday, November 21st. Deutsche Bank Aktiengesellschaft initiated coverage on shares of Bath & Body Works in a report on Thursday, January 8th. They set a “hold” rating and a $21.00 price objective on the stock. Finally, Wells Fargo & Company reduced their price objective on shares of Bath & Body Works from $33.00 to $25.00 and set an “overweight” rating for the company in a report on Friday, November 21st. Five equities research analysts have rated the stock with a Buy rating and thirteen have assigned a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $22.93.

More Bath & Body Works News

Here are the key news stories impacting Bath & Body Works this week:

• Negative Sentiment: Multiple law firms have either filed or are soliciting plaintiffs in a securities class action against Bath & Body Works alleging violations of Sections 10(b) and 20(a) and Rule 10b‑5, covering purchases between June 4, 2024 and November 19, 2025; lead‑plaintiff deadlines are being advertised around March 13–16, 2026. These notices signal active litigation and potential future settlement or judgment exposure. DJS Law Group Notice Rosen Law Firm Notice Kessler Topaz Notice

Insiders Place Their Bets

In related news, Director Steven E. Voskuil purchased 20,000 shares of Bath & Body Works stock in a transaction that occurred on Friday, November 21st. The stock was bought at an average price of $15.04 per share, for a total transaction of $300,800.00. Following the completion of the transaction, the director owned 33,925 shares in the company, valued at $510,232. This represents a 143.63% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Francis Hondal acquired 3,343 shares of the firm’s stock in a transaction that occurred on Friday, November 21st. The shares were bought at an average price of $14.99 per share, with a total value of $50,111.57. Following the acquisition, the director directly owned 21,554 shares of the company’s stock, valued at $323,094.46. The trade was a 18.36% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Over the last ninety days, insiders purchased 33,513 shares of company stock valued at $500,442. Insiders own 0.27% of the company’s stock.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.